Anti-GDF15 antibody

  • Description

  • Application Data


An antibody raised against growth/differentiation factor 15 (GDF15); a ligand that binds to transforming growth factor-beta (TGF) receptors with roles in obesity, cardiovascular disease, and cancer.

See full description

Application Data

Catalogue number crb2005605
Antibody Anti-GDF15 antibody
Antigen Peptide KLH conjugated synthetic peptide crb1200809e
Protein ID Q99988 Human GDF15
Aliases Growth/differentiation factor 15, GDF15, Macrophage inhibitory cytokine 1, MIC-1, NSAID-activated gene 1 protein, NAG-1, NSAID-regulated gene 1 protein, NRG-1, Placental TGF-beta, Placental bone morphogenetic protein, Prostate differentiation factor
Cross-Reactivity Human
Target Protein Species Human
Host Species Rabbit
Antibody Type Polyclonal
Concentration 1mg/ml Glycine (R1G), 1mg/ml Glycine (R2G)
Validation 1:1000 (ELISA)
Target GDF15
Storage Stabilisers The product should be stored at -20°C for short term storage and long term storage. Avoid repeated freeze/ thaw cycles.
Storage The product should be stored at -20°C for short term storage and long term storage. Avoid repeated freeze/ thaw cycles.

Baek et al., (2019). Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases. Pharmacology & therapeutics, 198: 46. PMID: 30790643.


Yang et al., (2017) GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med., 23(10): 1158. PMID: 28846099.

Material Safety Data Sheet (MSDS)

GDF15, also called Macrophage Inhibitory Cytokine 1 (MIC-1), is a secreted pleiotropic cytokine expressed by numerous tissues that functions as a disulphide-linked homodimer. Its binding to TGF receptor GFRAL activates the versatile SMAD pathway leading to SMAD transcription factor activation. This has been shown to happen when the cell is injured and an upregulation of GDF15 protein, a stress inducible cytokine. Increased GDF15 levels have been associated with hypoxia, inflammation, oxidative stress, myocardial ischemia, and notably cancer. Raised GDF15 levels are also associated with cardiovascular diseases such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction, and chronic kidney diseases in diabetes.

Other diseases associated with GDF15 include Hereditary Transthyretin Amyloidosis and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. GDF15 has thus been widely explored as a biomarker for disease prognosis and all-cause mortality.

Anti-GDF15 antibody

Cat No.Pack SizePriceQty.
Bulk Quote